
Click Therapeutics
Total Raised
$122.58MDeal Terms
1Click Therapeutics Funding, Click Therapeutics Valuation & Click Therapeutics Revenue
11 Fundings
Click Therapeutics's latest funding round was a Loan - II for $15M on April 15, 2022.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
---|---|---|---|---|---|---|
4/15/2022 | Loan - II | $15M | 1 | |||
10/22/2021 | Series B | $52M | 15 | |||
12/1/2020 | Debt - IV | $30M | 5 | |||
4/11/2020 | Loan | |||||
1/3/2019 | Partnership |
Date | 4/15/2022 | 10/22/2021 | 12/1/2020 | 4/11/2020 | 1/3/2019 |
---|---|---|---|---|---|
Round | Loan - II | Series B | Debt - IV | Loan | Partnership |
Amount | $15M | $52M | $30M | ||
Investors | |||||
Valuation | |||||
Revenue | |||||
Sources | 1 | 15 | 5 |
Click Therapeutics Deal Terms
1 Deal Term
Click Therapeutics's deal structure is available for 1 funding round, including their Series A from June 28, 2018.
Round | Series A |
---|---|
Funding Date | |
Pre-Money Valuation | |
Post-Money Valuation | |
Amount Raised | |
Shares Authorized | |
Issuance Price | |
Dividend Rate | |
Liquidation Preferences | |
Liquidation Price | |
Participation | |
Conversion Price | |
Anti Dilution | |
General Voting | |
Board Voting | |
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series A |
You May Also Like

Pear Therapeutics discovers, develops, and delivers clinically-validated Prescription Digital Therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effection solutions for payers.

Limbix makes virtual reality and digital treatment tools for therapists.

Quit Genius has created a gamified behavioral therapy app to help smokers quit smoking.

Happify is a LifeTech company that delivers digital therapeutics and care delivery models to improve mental and physical health. Happify Health’s safe, effective digital tools use scientific research from positive psychology, CBT, and mindfulness, combined with a gamified approach and technology, to impact everyday lives. Happify Health's clinically-validated platform provides global access to a comprehensive, evidence-based intervention catalog.

Komodo Health is a data company aggregating healthcare data. Specifically, Komodo aggregates hundreds of longitudinal, all-inclusive payer data sets including Medicare, through QECP accreditation by CMS.
Phil is a software therapy deployment platform, offering pharmaceutical manufacturers a modern alternative to traditional access, affordability and distribution options. Through its digital stakeholder experiences, patient access services, market access solutions and distribution models, pharma manufacturers are able to deliver affordable and timely therapy access to patients.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.